Clinical Dementia Rating (CDR) Scale
Why Use
Helps inform the level of care or support needed by the patient based on dementia severity.
When to Use
Use in patients with suspected cognitive decline to assess and stage the severity of dementia. Useful in tracking the progression of cognitive impairment over time.
Formula
Pearls / Pitfalls
Initially developed to stage Alzheimer disease (AD), but applicable to other forms of dementia. While structured, some elements of scoring rely on clinician judgment and patient/caregiver input, potentially introducing subjectivity. Score only as a decline from the patient’s previous usual level due to cognitive loss, rather than impairments from other factors.
Advice
Use the results to guide care plans, including the need for caregiver support, home health services, or long-term care options. Discuss the results with family members to provide them with a clear understanding of the patient’s needs and anticipated changes. For AD specifically, severity can guide pharmacologic strategies: Mild to moderate: Consider a trial of a cholinesterase inhibitor. Moderate to severe: The addition of memantine may be appropriate. Patients with early AD may be referred to a neurologist or dementia specialist for consideration of amyloid-targeting therapies. Reassess periodically to monitor disease progression, as scores may change over time.
More Information
Interpretation: CDR Stage of Dementia 0 Normal (not dementia) 0.5 Very mild 1 Mild 2 Moderate 3 Severe